AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 281: H1931-H1937, 2001;
0363-6135/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narayan, P.
Right arrow Articles by Lasley, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narayan, P.
Right arrow Articles by Lasley, R. D.
Vol. 281, Issue 5, H1931-H1937, November 2001

Annexin V staining during reperfusion detects cardiomyocytes with unique properties

Prakash Narayan, Robert M. Mentzer Jr., and Robert D. Lasley

Department of Surgery, University of Kentucky College of Medicine, Lexington, Kentucky 40536


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

With the use of markers of sarcolemmal membrane permeability, cardiomyocyte models of ischemic injury have primarily addressed necrotic death during ischemia. In the present study, we used annexin V-propidium iodide staining to examine apoptosis and necrosis after simulated ischemia and simulated reperfusion in rat ventricular myocytes. Annexin V binds phosphatidylserine, a phosphoaminolipid thought to be externalized during apoptosis or programmed cell death. Propidium iodide is a marker of cell necrosis. Under baseline conditions, <1% of cardiomyocytes stained positive for annexin V. After 20 or 60 min of simulated ischemia, there was no increase in annexin V staining, although 60-min simulated ischemia resulted in significant propidium iodide staining. Twenty minutes of simulated ischemia, followed by 20 or 60 min of simulated reperfusion, resulted in 8-10% of myocytes staining positive for annexin V. Annexin V-positive cells retained both rod-shaped morphology and contractile function but exhibited the decreased cell width indicative of cell shrinkage. Baseline mitochondrial free Ca2+ (111 ± 14 nM) was elevated in reperfused annexin V-negative cells (214 ± 22 nM), and further elevated in annexin V-positive myocytes (382 ± 9 nM). After 60 min of simulated reperfusion, caspase-3-like activity was observed in ~3% of myocytes, which had a rounded appearance and membrane blebs. These results suggest that the use of annexin V after simulated ischemia-reperfusion uncovers a population of cardiomyocytes whose characteristics appear to be consistent with cells undergoing apoptosis.

rat heart; ischemia-reperfusion; mitochondrial calcium


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

ISOLATED CARDIOMYOCYTE MODELS of simulated ischemia (SIsc) have lent much insight into the pathophysiology of myocardial ischemic injury. Free from neurohumoral influences and potentially confounding contributions from nonmyocyte cell types, these models have contributed to our understanding of both the ionic dyshomeostasis and the altered signal transduction accompanying ischemia (1, 7). In these studies (1, 7, 14), manipulations to protect the ischemic heart have largely focused on reducing necrotic cell death, which has typically been assessed by using indicators of sarcolemmal membrane permeability, such as trypan blue and enzyme release.

Results from several studies (6, 8, 21), however, indicate that reperfusion after myocardial ischemia can result in exacerbation of injury and apoptosis (programmed cell death). In fact, several studies (6, 8, 13, 21, 35) suggest that apoptosis is a reperfusion-related phenomenon. Because of reports (25, 34) indicating evidence of apoptosis in the peri-infarct and remote nonischemic zones of infarcted human myocardium, the mechanisms governing this death program have come under intense investigation. The majority of studies (5, 8, 21) examining myocardial reperfusion-related apoptosis have used techniques such as DNA fragmentation and evidence of DNA laddering. However, these techniques detect apoptosis at a very late stage, and cardiomyocytes with fragmented DNA have been reported (10, 17) to exhibit extensive membrane blebbing, mitochondrial and nuclear margination, and a condensed or rounded morphology. In contrast, data from numerous cell types have indicated that one of the earliest events in the apoptotic cascade is externalization of the phosphoaminolipid phosphatidylserine from the inner face of the plasma membrane to the outer cell surface (33). Fluorophore-labeled annexin V (a protein that exhibits nanomolar affinity for phosphatidylserine) binding to externalized phosphatidylserine has been extensively employed as a reliable marker of apoptosis (3, 13, 27).

If apoptosis is a physiologically relevant aspect of reperfusion injury and is truly unique from necrosis, as suggested by several noncardiac studies (20), then merely measuring cell death during ischemia based on membrane permeability may underestimate the extent of myocyte death during ischemia-reperfusion. In the present study, we examined the effects of SIsc and simulated reperfusion (SRP) in isolated rat ventricular myocytes by using annexin V-propidium iodide, markers of apoptosis and necrosis, respectively, morphology, mitochondrial free calcium concentration ([Ca2+]m), and twitch amplitude.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Isolation of ventricular myocytes. Ventricular myocytes were enzymatically dissociated from male Sprague-Dawley rats (350-400 g) as previously described (24). Cardiomyocytes were suspended in standard HEPES buffer composed of (in mM) 130 NaCl, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4, 10 HEPES, and 11 glucose (containing 200 µM CaCl2 at a pH of 7.4). This procedure routinely yielded >70% rod-shaped myocytes. For the experimental protocols, the same buffer with 1 mM CaCl2 was used. All data were collected within 6 h of myocyte isolation.

Myocyte imaging and analysis system. To visualize and quantify annexin V-propidium iodide staining, measurement of [Ca2+]m, and cardiomyocyte length, width, and twitch amplitude, we used an inverted microscope (model IX70, Olympus America; Melville, NY) equipped with a 75-W xenon arc lamp. Excitation and emission wavelengths were selected with the use of a variety of filter combinations. For functional measurements, cardiomyocytes were placed in a 0.3-ml recording chamber (Warner Instruments; Warrendale, PA), the floor of which was a 22 mm × 22 mm glass coverslip coated with laminin to enhance cell adherence. Both epifluorescence and the cardiomyocyte image (×200 magnification) were collected by the use of a charge-coupled device camera that was attached to a side port of the microscope. Image analysis was done with the use of a Pentium-based computer and custom-made software (Coyote Bay; Manchester, NH).

Annexin V-propidium iodide staining in cardiomyocytes. Myocytes were stained with fluorescein isothiocyanate (FITC), annexin V, and propidium iodide, as per the manufacturer's directions (Vybrant Apoptosis Assay Kit 2, Molecular Probes) and visualized under a fluorescence microscope. Cells were counted regardless of morphology. Cells not binding FITC-annexin V and excluding propidium iodide were classified as annexin V-negative (AN-ve) (26). Myocytes that bound FITC-annexin V [excitation wavelength (lambda ex) = 488 nm and emission wavelength (lambda em) = 520 nm] but excluded propidium iodide (lambda ex = 540 nm and lambda em = 630 nm) were termed annexin V-positive (AN+ve) and myocytes permeant to propidium iodide (regardless of whether or not they bound FITC-annexin V) were deemed necrotic (31).

Assay for caspase-3-like activity. The protease caspase 3 is a cysteine protease that cleaves substrates with a Asp-Glu-Val-Asp (DEVD) motif at the terminal aspartate (30). Myocytes were incubated with the FITC-conjugated cell permeant aminopeptide, GDEVDGI, and propidium iodide as per manufacturer's directions (OncoImmunin; Gaithersburg, MD). Uncleaved GDEVDGI is not fluorescent, but after cleavage by caspase-3-like proteases, the cleaved fractions fluoresce (lambda ex = 488 nm and lambda em = 520 nm).

Measurement of [Ca2+]m: use of rhod 2 and Mn2+ quenching. Myocytes were loaded with rhod 2-acetoxymethyl ester (10 µM; Molecular Probes; Eugene, OR) for 20 min, followed by washout of the dye. Aliquots of the rhod-2-labeled cell suspension were placed in the temperature-controlled recording chamber and suffused with HEPES buffer containing MnCl2 (100 µM, 20 min). Because some of the deesterified rhod 2 is distributed in the cytosolic compartment, it is necessary to eliminate the cytosolic component of the Ca2+ signal (23). Mn2+, which binds rhod 2 with greater affinity than Ca2+, quenches the cytosolic Ca2+ signal but does not enter mitochondrial compartment (at least over 120 min) (23). After 20-min exposure to MnCl2, suffusion with standard HEPES buffer was resumed and fluorescence measurements (lambda ex = 540 nm and lambda em = 580 nm) were made. Conversion of the fluorescence signal to [Ca2+] was done by the method of Delcamp et al. (4). [Ca2+]m (expressed in nM) was calculated using the equation
[Ca<SUP>2+</SUP>]<SUB>m</SUB><IT>=K</IT><SUB>d</SUB><IT>×</IT>[(R<IT>−</IT>R<SUB>min</SUB>)<IT>&cjs0823;  </IT>(R<SUB>max</SUB><IT>−</IT>R)]
where R is the measured fluorescence intensity (corrected for background fluorescence), Rmin is the fluorescence at zero calcium, and Rmax is the fluorescence under saturating [Ca2+] (2.5 mM). Rmin was derived by exposing myocytes to 25 µM digitonin in a Ca2+-free HEPES buffer containing 10 mM EGTA, and Rmax was derived by exposing the cardiomyocytes to HEPES buffer containing 2.5 mM CaCl2 (no EGTA). A dissociation constant (Kd) of 570 nM was used (Molecular Probes).

To validate our measurements of [Ca2+]m, separate aliquots of normoxic myocytes loaded with either the [Ca2+]m indicator rhod 2 (in the presence of Mn2+ quenching) or the cytosolic free Ca2+ indicator fluo 3 (10 µM) were exposed to the uncoupler/protonophore p-trifluoromethoxyphenylhydrazone (FCCP) (1 µM). The FCCP-induced changes in [Ca2+]m and cytoplasmic free Ca2+ were recorded.

Measurement of cell length, cell width, and twitch amplitude. Maximal cell length parallel to the longitudinal axis (cardiomyocyte length) and maximal cell width perpendicular to the longitudinal axis (cardiomyocyte width) was measured using a micrometer grid. Amplitude of cell shortening (in response to electrical stimulation at 0.5 Hz, 37°C), expressed as a percentage of diastolic cell length, was computed as described previously by our laboratory (24).

SIsc and SRP protocol. After a 60-min postisolation equilibration period, aliquots of cell suspensions were placed in 1.5-ml Eppendorff tubes and pelleted at 100 g for 10 s, resulting in a pellet occupying a volume of ~100 µl. Excess supernatant was removed, leaving a thin fluid layer above the pellet. Mineral oil (200 µl) was then layered on top of the pellet to limit gaseous diffusion, and the Eppendorff tubes were placed in a nonshaking water bath at 37°C to simulate normothermic ischemia. At the end of ischemia, the mineral oil was aspirated and the cardiomyocytes resuspended either in phosphate-buffered saline or in standard HEPES buffer (gassed with 100% O2, 37°C).

Myocytes were submitted to either: 1) 20- or 60-min SIsc alone or 2) 20-min SIsc + 20- or 60-min SRP. To assess cardiomyocyte injury during SIsc, myocytes were resuspended in phosphate-buffered saline and stained with the annexin V-propidium iodide. To assess cardiomyocyte injury during SRP, myocytes were resuspended in oxygenated HEPES buffer and stained with the dyes. In certain experiments, SRP conditions were modified by the omission of either Ca2+ or O2 from the HEPES buffer. The latter was accomplished by gassing the buffer with 100% N2 (resulting in a PO2 of ~30 mmHg). Cardiomyocytes suspended under normoxic conditions served as time controls.

Finally, to determine the effects of a reactive oxygen species (ROS) generating system on cell injury, a separate aliquot of myocytes (nonischemic) was exposed to 200 µM H2O2 for 20 min. After resuspension in standard HEPES buffer, cells were stained with FITC-annexin V-propidium iodide.

Data analysis. For quantification of AN-ve, AN+ve, and necrotic cells, ~300 cardiomyocytes were counted per heart per group and expressed as a percentage of all cardiomyocytes counted. Data are expressed as means ± SE. Within-group differences were determined by one-way analysis of variance (ANOVA), followed by Newman-Keuls post hoc analysis. A P value <0.05 was considered statistically significant.

Cell length, width, and twitch amplitude, and [Ca2+]m, were expressed as means ± SE. Statistical analysis was done by one-way ANOVA, followed by Newman-Keuls post hoc analysis. A P value <0.05 was considered statistically significant.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Under baseline (nonischemic) conditions, the percentage of AN-ve, AN+ve, and necrotic cardiomyocytes, as determined by FITC-annexin V-propidium iodide staining, was 77.0 ± 1.5, 0.8 ± 0.2, and 22.0 ± 1.7, respectively (n = 12 hearts). Myocytes suspended under normoxic conditions retained baseline viability over the 4- to 5-h experimental period. Twenty or sixty minutes of SIsc alone did not result in an increase in AN + ve cells (~0.9% in each group, n = 5 hearts/group). Twenty minutes of SIsc did not result in additional necrosis from baseline (24.0 ± 2.1%), but sixty minutes of SIsc was associated with significant cardiomyocyte necrosis (47.7 ± 3.0%, P < 0.05 vs. baseline).

Figure 1, A-C, show the effects of 20 min of SIsc and 20 min of SRP on cardiomyocytes. As seen in Fig. 1A, under normal lighting conditions, there are two rod-shaped myocytes and one rounded myocyte. Only the rounded myocyte was permeable to propidium iodide indicating necrosis (Fig. 1B). As shown in Fig. 1C, of the two apparently normal, rod-shaped cardiomyocytes, one fluoresced green due to FITC-annexin V binding and was therefore classified as AN+ve.


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 1.   After 20 min of simulated ischemia (SIsc) and 20 min of simulated reperfusion (SRP) cardiomyocytes were stained with fluorescein isothiocyanate (FITC)-annexin (AN) V/propidium iodide and viewed under several lighting conditions. A: bright field, showing two rod-shaped and one rounded myocyte. B: propidium iodide fluorescence [excitation wavelength (lambda ex) = 540 nm, emission wavelength (lambda em) = 630 nm], where the nucleii of rounded myocyte is visible, indicating that this cell is necrotic. C: FITC-annexin V fluorescence (lambda ex = 490 nm, lambda em = 520 nm), rod-shaped cardiomyocyte, excluding propidium iodide (in B) fluoresces green and is classified as annexin V-positive (AN+ve).

Effects of 20-min SIsc, followed by 20- or 60-min SRP on the percentage of cardiomyocytes staining positive for annexin V are shown in Fig. 2. Compared with baseline, 20 min SRP was associated with an ~12-fold increase in AN+ve cells. Extending reperfusion time from 20 to 60 min did not result in a significant increase in this value. The percentages of necrotic cells at 20 and 60 min SRP were 28.4 ± 2.2 and 34.0 ± 3.0, respectively (both values, P < 0.05 vs. baseline). When myocytes (n = 3 hearts) were reperfused (20 min) in the absence of extracellular Ca2+, the percentage of AN+ve cells was 1.5 ± 0.3, a value significantly lower compared with myocytes reperfused in the presence of extracellular Ca2+ (7.5 ± 1.5%). In myocytes (n = 3 hearts) subjected to 20-min SIsc and reperfused (20 min) with buffer saturated with 100% N2, 4.1 ± 0.5% of cells stained AN+ve (P < 0.05 vs. control HEPES reperfusion). Finally, exposure of normoxic cardiomyocytes to H2O2 (n = 3 hearts) resulted in 14.6 ± 2.1% AN+ve cells.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of 20-min SIsc (ISC), followed by 20- or 60-min SRP (RP) on annexin V staining in ventricular myocytes. *P < 0.05 vs. baseline.

Although AN+ve cardiomyocytes exhibited rod-shaped morphology (Fig. 1C), closer examination revealed that these cells exhibited decreased cell width. Figure 3A shows cell length and width in baseline (nonischemic), reperfused AN-ve and AN+ve cardiomyocytes (n = 35 cells / group). Whereas cell length was not different between groups, cell width in the AN+ve cells was about one-half that of the AN-ve myocytes. Consequently, cell length-to-width ratio was 6.8 ± 0.4 in AN+ve cardiomyocytes, twice the ratio (3.4 ± 0.1) observed in AN-ve cells (Fig. 3B). Despite significantly different cell length-to-width ratio, the twitch amplitude in both groups (n = 15 cells/group) was comparable (AN-ve, 5.3 ± 0.4%; AN+ve, 4.5 ± 0.5%) but considerably less than that observed in cardiomyocytes subjected to normoxic, normothermic incubation (9.3 ± 1.0%).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3.   Diastolic length and width (A) and length-to-width ratio (B) in baseline (nonischemic) and reperfused annexin V negative (AN-ve) and AN+ve myocytes. *P < 0.05 vs. baseline; #P < 0.05 vs. AN-ve.

It has been reported (23) that although cytosolic free Ca2+ levels may be normal in reperfused rod-shaped myocytes, [Ca2+]m is elevated. Because increased [Ca2+]m is thought to play a role in initiating apoptosis (28), we measured [Ca2+]m in nonischemic and reperfused myocytes. As shown in Fig. 4, nonischemic cells exhibited a baseline [Ca2+]m of 111 ± 14 nM. After SRP, [Ca2+]m in AN-ve cells was 214 ± 22 nM and further elevated in AN+ve myocytes 382 ± 9 nM.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 4.   Mitochondrial free Ca2+ concentration ([Ca2+]m) in nonischemic cardiomyocytes and myocytes subjected to 20 min of SIsc and 20 min of SRP. Reperfused myocytes were subdivided into AN-ve and AN+ve groups. [Ca2+]m was measured using rhod 2 and the Mn2+ quenching technique described in METHODS. *P < 0.05 vs. baseline; #P < 0.05 vs. AN-ve.

Activation of the executioner enzyme caspase 3 is a hallmark feature of the apoptotic cascade (5, 17, 30) and caspase-3-like activity was examined in cardiomyocytes subjected to 20 SIsc, followed by 20- or 60-min SRP. Caspase-3-like activity appeared in 0.03 ± 0.02% cells after 20-min SRP and in 2.85 ± 0.30% of cardiomyocytes after 60-min SRP. Myocytes staining positive for caspase 3 exhibited membrane blebs and a rounded morphology.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

In the present study, rat ventricular myocytes subjected to brief SIsc and SRP, but not SIsc alone, exhibited a significant increase in annexin V staining. Rod-shaped myocytes staining positive for annexin V excluded propidium iodide, indicating maintenance of sarcolemmal integrity. However, these same cells exhibited significantly decreased cell width and increased [Ca2+]m levels. During SRP, caspase-3-like activity was observed in cells with a rounded morphology and membrane blebbing. These results suggest that use of annexin V in the setting of SIsc-SRP uncovers a population of cardiomyocytes whose characteristics appear to be consistent with cells undergoing apoptosis.

The use of isolated adult mammalian cardiomyocyte models of SIsc-SRP can serve to distinguish between events occurring during ischemia versus those resulting from reperfusion and also provide a controlled environment for studying mechanisms underlying ischemia-reperfusion injury. However, the majority of single-cell studies (1, 7, 14) have typically addressed necrotic death during ischemia using markers of membrane permeability such as trypan blue staining and enzyme release. Although reperfusion can be associated with cardiomyocyte apoptosis (8, 21, 35), there have been few, if any, studies examining the deleterious effects of reperfusion (12). In fact, unlike necrosis, which occurs during ischemia-reperfusion, the majority of studies (6, 8, 21) suggest that myocardial apoptosis is a reperfusion-related phenomenon.

In the present study, necrotic cell death was assessed with propidium iodide, which stains the nuclei of cells with permeant membranes (15, 30). Our data indicated that only the long (60 min) simulated ischemic interval was associated with significant cardiomyocyte necrosis. On the other hand, SRP (but not SIsc alone) was associated with significant annexin V binding in cells excluding propidium iodide. Annexin V, a protein originally isolated from human placenta, but since found in other tissue, binds phosphatidylserine, a phosphoaminolipid that is externalized onto the outer surface of the plasma membrane during apoptosis or programmed cell death (33). When myocytes were reperfused with HEPES buffer lacking Ca2+ or saturated with N2 (PO2 ~30 mmHg), annexin V staining was significantly reduced. The exposure of nonischemic cardiomyocytes to the ROS generator H2O2 also resulted in a significant increase in annexin V-positive cells. These observations are consistent with the hypothesis that apoptosis occurs primarily during reperfusion (6, 8, 21) and is associated with intracellular oxidative stress and altered Ca2+ handling (15, 35, 29).

In addition to excluding propidium iodide, which is indicative of a noncompromised sarcolemmal membrane, AN+ve cells also maintained rod-shaped morphology. Hypoxia-reoxygenation studies (9, 12) in isolated cardiomyocytes have indicated that retention of rod-shaped morphology is critically dependent on maintenance of intracellular ATP levels. Thus our data suggested the presence of some intracellular ATP in AN+ve cells. Despite the appearance of rod-shaped morphology, detailed examination of annexin V myocytes revealed that these cells exhibited decreased cell width, indicative of cell shrinkage. This is in contrast to reperfused AN-ve cells, which exhibited the increased cell width indicative of cell swelling. Measurement of unloaded shortening after sRP was not different between AN+ve and AN-ve myocytes, although shortening was reduced compared with nonischemic cells.

It has been reported (23) that while cytosolic free Ca2+ levels may be normal in reperfused rod-shaped myocytes, [Ca2+]m is elevated. Furthermore, myocardial reperfusion injury has been intimately linked to [Ca2+]m overload (22, 23). Data from neuronal studies have suggested that increased [Ca2+]m is associated with release of cytochrome c from the mitochondria (28), an early step in the apoptotic cascade (5). In the present study, use of the [Ca2+]m indicator rhod 2 revealed that reperfused myocytes exhibited increased [Ca2+]m compared with nonischemic cells. However, the salient finding was that [Ca2+]m in AN+ve cells was significantly greater [Ca2+]m than AN-ve cells. Validation of our [Ca2+]m measurements was made by application of the uncoupler protonophore FCCP to normoxic cells, loaded with either the [Ca2+]m indicator rhod 2 (in the presence of Mn2+ quenching) or the cytosolic free Ca2+ indicator fluo 3. This protocol resulted in an FCCP-induced decrease in [Ca2+]m and an increase in cytosolic free Ca2+ (data not shown). Thus, whereas increased [Ca2+]m has been implicated in the initiation of apoptosis, to our knowledge, this is the first report of elevated [Ca2+]m during cardiomyocyte apoptosis.

Activation of executioner caspases, such as caspase 3, is a hallmark feature of apoptosis and is thought to be associated with irreversible morphological and nuclear damage (17, 26). Caspase-3-like activity appeared in cardiomyocytes after 20 min of SIsc and 60 min of SRP. However, the incidence of annexin V staining after 60 min of SRP was ~3-fold higher than the incidence of caspase-3-like activity. Furthermore, cells exhibiting caspase-3-like activity had a rounded morphology with membrane blebs. These findings are suggestive of an ongoing cardiomyocyte apoptotic program before caspase activation and loss of membrane integrity.

All of the characteristics that distinguished AN+ve myocytes from AN-ve cells and necrotic cells in the present study support the hypothesis that these cells are in the early stages of apoptosis. Requirement of reperfusion for the apoptotic program is well documented (6, 8, 21). Intracellular ATP is critical for execution of apoptosis (5). The presence of an intact cell membrane, cell shrinkage, and increased [Ca2+]m is a hallmark characteristic of apoptotic cells (5, 28). Induction of the apoptotic program in cultured cardiomyocytes in response to exogenous ROS has also been reported (15, 31). Given these observations, the well-accepted use of annexin V as a reliable indicator of ongoing apoptosis (27, 30) and the appearance of caspase-3-like activity during SRP, our results suggest that in addition to necrosis, SRP after SIsc is accompanied by a cardiomyocyte apoptosis program.

There were several limitations in the present study. First, the relatively short SRP times (20 and 60 min) most likely underestimated the true extent of cardiomyocyte apoptosis and necrosis. A second limitation pertains to the caspase detection assay, which may not be entirely specific for caspase-3 activity, and accordingly, we have chosen to use the terminology "caspase-3-like" activity. Furthermore, the true sensitivity of this assay for detection of caspase-3-like activity is unknown. Nevertheless, this assay has been used for detection of caspase-3-like activity in individual cardiomyocytes (30) and in other nonmyocyte studies (11, 36). Third, the use of an isolated cardiomyocyte model may have underestimated the true extent of injury compared with an in vivo preparation. However, use of an isolated myocyte preparation permits both mechanistic determinations and morphological characterization of cardiomyocyte injury. Fourth, the present study did not examine the mechanism for phosphatidylserine externalization during SRP. However, data from other cell types indicate that both oxidative stress and calcium overload can result in externalization of this phosphaminolipid (2, 16).

In conclusion, our findings indicate that annexin V staining detects a subpopulation of myocytes that exhibit characteristics similar to cells associated with apoptosis. The use of indicators of apoptosis, such as annexin V, enables identification of myocytes in the early stages of apoptosis, when they still retain rod-shaped morphology and contractile capacity. Early detection of apoptosis will not only facilitate mechanistic studies relating to this death program but may also aid in the development of therapeutic interventions that can potentially arrest this program.


    ACKNOWLEDGEMENTS

We thank Eric L. Kilpatrick and Dr. M. Salik Jahania for assistance in the completion of this study.


    FOOTNOTES

This work was supported in part by the National Institutes of Health Grant HL-34579 (to R. M. Mentzer, Jr.) and a University of Kentucky Medical Center Research grant (to P. Narayan).

Address for reprint requests and other correspondence: P. Narayan, MN269, Dept. of Surgery, Univ. of Kentucky, 800 Rose St., Lexington, KY 40536 (E-mail: pnaraya{at}pop.uky.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 12 April 2001; accepted in final form 6 July 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Armstrong, SC, Shivell LC, and Ganote CE. Sarcolemmal blebs and osmotic fragility as correlates of irreversible ischemic injury in preconditioned isolated rabbit cardiomyocytes. J Mol Cell Cardiol 33: 149-160, 2001[Web of Science][Medline].

2.   Bevers, EM, Comfurius P, Dekkers DW, Harmsma M, and Zwaal RF. Transmembrane phospholipid distribution in blood cells: control mechanisms and pathophysiological significance (Review). Biol Chem 379: 973-986, 1998.

3.   Clodi, K, Kliche KO, Zhao S, Weidner D, Schenk T, Consoli U, Jiang S, Snell V, and Andreeff M. Cell-surface exposure of phosphatidylserine correlates with the stage of fludarabine-induced apoptosis in chronic lymphocytic leukemia and expression of apoptosis-regulating genes. Cytometry 40: 19-25, 2000[Web of Science][Medline].

4.   Delcamp, TJ, Dales C, Ralenkotter L, Cole PS, and Hadley RW. Intramitochondrial [Ca2+] and membrane potential in ventricular myocytes exposed to anoxia-reoxygenation. Am J Physiol Heart Circ Physiol 275: H484-H494, 1998[Abstract/Free Full Text].

5.   Elsasser, A, Suzuki K, and Schaper J. Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. J Mol Cell Cardiol 32: 711-724, 2000[Web of Science][Medline].

6.   Fliss, H. Accelerated apoptosis in reperfused myocardium: friend of foe? Basic Res Cardiol 93: 90-93, 1998[Web of Science][Medline].

7.   Ganote, CE, and Armstrong SC. Ischaemia and the myocyte cytoskeleton: review and speculation. Cardiovasc Res 27: 1387-1403, 1993[Free Full Text].

8.   Gottlieb, RA, Burleson KO, Kloner RA, Babior BM, and Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621-1628, 1994.

9.   Haworth, RA, Hunter DR, and Berkoff HA. Contracture in isolated adult rat heart cells. Role of Ca2+, ATP, and compartmentation. Circ Res 49: 1119-1128, 1981[Abstract/Free Full Text].

10.   Henaff, M, Hatem SN, and Mercadier JJ. Low catecholamine concentrations protect adult rat ventricular myocytes against apoptosis through cAMP-dependent extracellular signal-regulated kinase activation. Mol Pharmacol 58: 1546-1553, 2000[Abstract/Free Full Text].

11.   Hirata, H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, Okasaki T, Yamamoto K, and Sasada M. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med 187: 587-600, 1998[Abstract/Free Full Text].

12.   Hohl, CM, and Altschuld RA. Response of isolated adult canine cardiac myocytes to prolonged hypoxia and reoxygenation. Am J Physiol Cell Physiol 260: C383-C391, 1991[Abstract/Free Full Text].

13.   Hreniuk, D, Garay M, Gaarde W, Monia BP, McKay RA, and Cioffi CL. Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes. Mol Pharmacol 59: 867-74, 2001[Abstract/Free Full Text].

14.   Huh, J, Gross GJ, Nagase H, and Liang BT. Protection of cardiac myocytes via delta 1-opioid receptors, protein kinase C, and mitochondrial KATP channels. Am J Physiol Heart Circ Physiol 280: H377-H383, 2001[Abstract/Free Full Text].

15.   Inserte, J, Taimor G, Hofstaetter B, Garcia-Dorado D, and Piper HM. Influence of simulated ischemia on apoptosis induction by oxidative stress in adult cardiomyocytes of rats. Am J Physiol Heart Circ Physiol 278: H94-H99, 2000[Abstract/Free Full Text].

16.   Kagan, VE, Fabisiak JP, Shvedova AA, Tyurina YY, Tyurin VA, Schor NF, and Kawai K. Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis (Review). FEBS Lett 477: 1-7, 2000[Web of Science][Medline].

17.   Kang, PM, Haunstetter A, Aoki H, Usheva A, and Izumo S. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res 87: 118-125, 2000[Abstract/Free Full Text].

18.   Kukreja, RC, and Janin Y. Reperfusion injury: basic concepts and protection strategies. J Thromb Thrombolysis 4: 7-24, 1997[Medline].

19.   Li, Q, Hohl CM, Altschuld RA, and Stokes BT. Energy depletion-repletion and calcium transients in single cardiomyocytes. Am J Physiol Cell Physiol 257: C427-C434, 1989[Abstract/Free Full Text].

20.   Martin, LJ. Neuronal cell death in nervous system development, disease, and injury (Review). Int J Mol Med 7: 455-478, 2001[Web of Science][Medline].

21.   Maulik, N, Yoshida T, and Das DK. Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. Free Radic Biol Med 24: 869-875, 1998[Web of Science][Medline].

22.   Miyamae, M, Camacho SA, Weiner MW, and Figueredo VM. Attenuation of postischemic reperfusion injury is related to prevention of [Ca2+]m overload in rat hearts. Am J Physiol Heart Circ Physiol 271: H2145-H2153, 1996[Abstract/Free Full Text].

23.   Miyata, H, Lakatta EG, Stern MD, and Silverman HS. Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia. Circ Res 71: 605-613, 1992[Abstract/Free Full Text].

24.   Narayan, P, Mentzer RM, Jr, and Lasley RD. Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes. J Mol Cell Cardiol 33: 121-129, 2001[Web of Science][Medline].

25.   Olivetti, G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E, Gambert SR, Cigola E, and Anversa P. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 28: 2005-2016, 1996[Web of Science][Medline].

26.   Porter, AG, and Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6: 99-104, 1999[Web of Science][Medline].

27.   Rucker-Martin, C, Henaff M, Hatem SN, Delpy E, and Mercadier JJ. Early re-distribution of plasma membrane phosphatidylserine during apoptosis of adult rat ventricular myocytes in vitro. Basic Res Cardiol 94: 171-179, 1999[Web of Science][Medline].

28.   Schild, L, Keilhoff G, Augustin W, Reiser G, and Striggow F. Distinct Ca2+ thresholds determine cytochrome c release or permeability transition pore opening in brain mitochondria. FASEB J 15: 565-567, 2001[Free Full Text].

29.   Shen, HM, Dong SY, and Ong CN. Critical role of calcium overloading in cadmium-induced apoptosis in mouse thymocytes. Toxicol Appl Pharmacol 171: 12-19, 2001[Web of Science][Medline].

30.   Suzuki, K, Kostin S, Person V, Elsasser, and Schaper J. Time course of the apoptotic cascade and effects of caspase inhibitors in adult rat ventricular cardiomyocytes. J Mol Cell Cardiol 33: 983-994, 2001[Web of Science][Medline].

31.   Taimor, G, Hofstaetter B, and Piper HM. Apoptosis induction by nitric oxide in adult cardiomyocytes via cGMP-signaling and its impairment after simulated ischemia. Cardiovasc Res 45: 588-594, 2000[Abstract/Free Full Text].

32.   Toyoda, Y, Di Gregorio V, Parker RA, Levitsky S, and McCully JD. Anti-stunning and anti-infarct effects of adenosine-enhanced ischemic preconditioning. Circulation 102: III326-III331, 2000[Abstract/Free Full Text].

33.   Van Engeland, M, Nieland LJ, Ramaekers FC, Schutte B, and Reutelingsperger CP. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31: 1-9, 1998[Web of Science][Medline].

34.   Veinot, JP, Gattinger DA, and Fliss H. Early apoptosis in human myocardial infarcts. Hum Pathol 28: 485-492, 1997[Web of Science][Medline].

35.   Webster, KA, Discher DJ, Kaiser S, Hernandez O, Sato B, and Bishopric NH. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J Clin Invest 104: 239-252, 1999[Web of Science][Medline].

36.   Zapata, JM, Takahashi R, Salvesen GS, and Reed JC. Granzyme release and caspase activation in activated human T-lymphocytes. J Biol Chem 273: 6916-6920, 1998[Abstract/Free Full Text].


Am J Physiol Heart Circ Physiol 281(5):H1931-H1937
0363-6135/01 $5.00 Copyright © 2001 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Shan, R. B. Marchase, and J. C. Chatham
Overexpression of TRPC3 increases apoptosis but not necrosis in response to ischemia-reperfusion in adult mouse cardiomyocytes
Am J Physiol Cell Physiol, March 1, 2008; 294(3): C833 - C841.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. S. Tappia, M. S. Nijjar, A. Mahay, N. Aroutiounova, and N. S. Dhalla
Phospholipid profile of developing heart of rats exposed to low-protein diet in pregnancy
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1400 - R1406.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H.-Y. Sun, N.-P. Wang, F. Kerendi, M. Halkos, H. Kin, R. A. Guyton, J. Vinten-Johansen, and Z.-Q. Zhao
Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload
Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1900 - H1908.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Cai, S. Ahmad, W. G. Jiang, J. Huang, C. D. Kontos, M. Boulton, and A. Ahmed
Activation of Vascular Endothelial Growth Factor Receptor-1 Sustains Angiogenesis and Bcl-2 Expression Via the Phosphatidylinositol 3-Kinase Pathway in Endothelial Cells
Diabetes, December 1, 2003; 52(12): 2959 - 2968.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Zhang, I. Fantozzi, D. D. Tigno, E. S. Yi, O. Platoshyn, P. A. Thistlethwaite, J. M. Kriett, G. Yung, L. J. Rubin, and J. X.-J. Yuan
Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L740 - L754.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
P A J Krijnen, R Nijmeijer, C J L M Meijer, C A Visser, C E Hack, and H W M Niessen
Apoptosis in myocardial ischaemia and infarction
J. Clin. Pathol., November 1, 2002; 55(11): 801 - 811.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narayan, P.
Right arrow Articles by Lasley, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narayan, P.
Right arrow Articles by Lasley, R. D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online